✦ LIBER ✦

Pioglitazone does not affect the risk of kidney cancer in patients with type 2 diabetes

✍ Scribed by Tseng, Chin-Hsiao

Book ID: 122186145
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 237 KB
Volume: 63
Category: Article
ISSN: 1532-8600
DOI: 10.1016/j.metabol.2014.04.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pioglitazone and oral cancer risk in pat

Pioglitazone and oral cancer risk in patients with type 2 diabetes

✍ Tseng, Chin-Hsiao 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Pioglitazone and thyroid cancer risk in

Pioglitazone and thyroid cancer risk in patients with type 2 diabetes

✍ Tseng, Chin-Hsiao 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 84 KB

Pioglitazone reduces risk of recurrent s

Pioglitazone reduces risk of recurrent stroke in patients with type 2 diabetes

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

The insulin sensitiser pioglitazone does

The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin

✍ J. E. Tooke; L. M. Elston; K. M. Gooding; C. I. Ball; D. M. Mawson; J. Piper; R. 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 114 KB

Safety and Tolerability of Pioglitazone

Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes

✍ Professor John Dormandy, Mondira Bhattacharya, Anne-Ruth van Troostenburg de Bru 📂 Article 📅 2009 🏛 Springer International Publishing AG 🌐 English ⚖ 289 KB

Sitagliptin treatment of patients with t

Sitagliptin treatment of patients with type 2 diabetes does not affect CD4+ T-cell activation

✍ Perrin C. White; Heidi Chamberlain-Shea; Maria-Teresa de la Morena 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 142 KB